The Nomination and Remuneration Committee of the Board of Directors of the Company approved, via a resolution by circulation on Saturday, July 25, 2026, the grant of 45,000 (Forty-Five Thousand) Stock Options to eligible employees of the Company. This grant is made under the Fusion Employee Stock Option Plan 2023 (ESOP 2023).
The disclosure is made in accordance with SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026, with detailed information provided in an enclosed Annexure A.
Key Details from Annexure A:
- Compliance: The ESOP 2023 scheme is in compliance with the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
- Total Options Granted: 45,000 stock options.
- Exercise Price: The options were granted at an exercise price of ₹216.48 per stock option. This price is equal to the closing price of the company's stock on the National Stock Exchange of India Limited (NSE) on July 24, 2026.
- Vesting Schedule: The options shall vest no earlier than 1 year from the Grant Date (July 25, 2026) and within the maximum vesting period prescribed in the ESOP 2023 plan.
- Exercise Period: The options may be exercised within 8 (Eight) years from the date of their vesting.
Details for options exercised, money realized, shares arising from exercise, lapsed options, term variations, and diluted EPS are marked as "Not Applicable" for this grant announcement.
The letter was issued by Vikrant Sadana, Company Secretary and Compliance Officer, and is also available on the company's website at www.fusionfin.com.